Radioimmunotherapy with 131I-Bevacizumab as a Specific Molecule for Cells with Overexpression of the Vascular Endothelial Growth Factor-Reference-Cited by-同舟云学术

Radioimmunotherapy with 131I-Bevacizumab as a Specific Molecule for Cells with Overexpression of the Vascular Endothelial Growth Factor

Published:2012-09 Issue:7 Volume:27 Page:420-425
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Ashrafi Saeb Ahmad¹,Hosseinimehr Seyed Jalal¹,Varmira Kambiz¹,Abedi Seyed Mohammad²

Affiliation:

1. Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.

2. Department of Radiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2012.1224

Reference27 articles.

1. Antibody-targeted radiation cancer therapy

2. The radiation biology of radioimmunotherapy

3. Radioimmunotherapy of B-cell non-Hodgkin's lymphoma

4. Radioimmunotherapy with Iodine-131 Tositumomab in Patients with Low-Grade Non-Hodgkin's B-Cell Lymphoma Does Not Induce Loss of Acquired Humoral Immunity against Common Antigens

5. EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vivo Preclinical Assessment of the VEGF Targeting Potential of the Newly Synthesized [52Mn]Mn-DOTAGA-Bevacizumab Using Experimental Cervix Carcinoma Mouse Model;Diagnostics;2023-01-08

2. Delivery of radioimmunotherapy for solid tumors;Systemic Drug Delivery Strategies;2022

3. The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy;Cancers;2021-03-03

4. Development of 131I-ixolaris as a theranostic agent: metastatic melanoma preclinical studies;Clinical & Experimental Metastasis;2020-05-11

5. Radiopharmaceuticals for Breast Cancer and Neuroendocrine Tumors: Two Examples of How Tissue Characterization May Influence the Choice of Therapy;Cancers;2020-03-25